Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sandow

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Journal of Proteomics|May 26, 2020
Identification of novel interacting partners of the NEDD4 ubiquitin ligase in mouse testisJantinaA Manning, Simon P Windley, Jarrod J Sandow, et al.
Acta Endocrinologica|February 1, 1987
LRH agonist buserelin as a post-partum contraceptive: lack of biological activity of buserelin in breast milkP J Dewart, A S McNeilly, S K Smith, et al.
Maturitas|July 1, 1985
Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal womenR W Shaw, R H Kerr-Wilson, H M Fraser, et al.
Fertility and Sterility|May 1, 1978
Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapyJ Happ, F Kollmann, C Krawehl, et al.
Cell Death Discovery|August 20, 2025
Phospholipid scramblase 1 (PLSCR1) is a novel substrate of NEDD4-2 (NEDD4L) mediated ubiquitinationMeriam Shabbar, Jantina A Manning, Yoon Lim, et al.
Proteomics. Clinical Applications|April 28, 2017
Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell deathJarrod J Sandow, Giuseppe Infusini, Aliaksei Z Holik, et al.
Journal of Pharmaceutical Sciences|March 9, 2000
Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epitheliumM C Schmidt, D Simmen, M Hilbe, et al.
Cancers|November 6, 2019
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1Nicholas P D Liau, Artem Laktyushin, Rhiannon Morris, et al.
Acta Endocrinologica|March 1, 1989
Two-monthly depot gonadotropin releasing hormone agonist (buserelin) for treatment of prostatic cancerJ H Waxman, J Sandow, P Abel, et al.
Autophagy|October 28, 2020
Cp1/cathepsin L is required for autolysosomal clearance in <i>Drosophila</i>Tianqi Xu, Shannon Nicolson, Jarrod J Sandow, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Journal of Proteomics|May 26, 2020
Identification of novel interacting partners of the NEDD4 ubiquitin ligase in mouse testisJantinaA Manning, Simon P Windley, Jarrod J Sandow, et al.
Acta Endocrinologica|February 1, 1987
LRH agonist buserelin as a post-partum contraceptive: lack of biological activity of buserelin in breast milkP J Dewart, A S McNeilly, S K Smith, et al.
Maturitas|July 1, 1985
Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal womenR W Shaw, R H Kerr-Wilson, H M Fraser, et al.
Fertility and Sterility|May 1, 1978
Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapyJ Happ, F Kollmann, C Krawehl, et al.
Cell Death Discovery|August 20, 2025
Phospholipid scramblase 1 (PLSCR1) is a novel substrate of NEDD4-2 (NEDD4L) mediated ubiquitinationMeriam Shabbar, Jantina A Manning, Yoon Lim, et al.
Proteomics. Clinical Applications|April 28, 2017
Quantitative proteomic analysis of EZH2 inhibition in acute myeloid leukemia reveals the targets and pathways that precede the induction of cell deathJarrod J Sandow, Giuseppe Infusini, Aliaksei Z Holik, et al.
Journal of Pharmaceutical Sciences|March 9, 2000
Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epitheliumM C Schmidt, D Simmen, M Hilbe, et al.
Cancers|November 6, 2019
Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1Nicholas P D Liau, Artem Laktyushin, Rhiannon Morris, et al.
Acta Endocrinologica|March 1, 1989
Two-monthly depot gonadotropin releasing hormone agonist (buserelin) for treatment of prostatic cancerJ H Waxman, J Sandow, P Abel, et al.
Autophagy|October 28, 2020
Cp1/cathepsin L is required for autolysosomal clearance in <i>Drosophila</i>Tianqi Xu, Shannon Nicolson, Jarrod J Sandow, et al.
Pageof 19